Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) News
Latest headlines that mention AMLX, newest first · each headline opens the original publisher
- Last price
- $27.09
- Day change
- -0.40%
- Next earnings
- 2026-11-05
AMLX headlines
latest coverageAmylyx looks promising, but a pullback would improve the opportunity.
Eli Lilly is currently leading the GLP-1 market, but Amylyx is seeing strong results from its GLP-1 drug candidate.
The biotech delivered excellent news from the laboratory.
GLP-1 drugs aren't just for weight loss.
Amylyx stock skyrocketed Tuesday after its GLP-1 drug reduced hypoglycemia in patients who've undergone bariatric surgery. The post A New Use for GLP-1s? Amylyx Pharma Catapults To 3-Year High appeared first on Investor's Business Daily .
LUCIDITY data readout expected late August or early September.
AMLX news alerts
Get an alert by email or push when a new headline mentions AMLX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.